Corcym has announced positive mid-term data from a sub-analysis of its Perceval Plus sutureless aortic heart valve as part of the MANTRA clinical trial. The data featured in an oral presentation today at the annual meeting of the European Association for Cardio-Thoracic Surgery (EACTS, 7–10 October, Barcelona, Spain). The study is the longest follow-up available … Continue reading EACTS 2026: Positive mid-term results seen with sutureless aortic valve